Director · ALTERITY THERAPEUTICS LTD · ALTERITY THERAPEUTICS LTD — Unlisted option exp 15 Jun 2031
Side
A
Value
—
Shares
2.00M
Price
—
Executed
Jun 15, 2026
Disclosed
Jun 23, 2026
Disclosure timeline8 days from execution to publication · legal deadline 2 business days
Jun 15 executedJun 23, 2026 disclosed
ATHE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+10 / 15
Disclosed 6 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ALTERITY THERAPEUTICS LTD — Unlisted option exp 15 Jun 2031
Ticker
ATHE
Shares
2.00M
Price per share
$0
Execution date (reported)
Jun 15, 2026
Owned after transaction
2.00M shares
Days from execution to publication
8
What this establishes
Babarczy Julian Michael filed this Form 4 reporting a grant or award of ATHE on Jun 15, 2026. It became public on Jun 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Babarczy Julian Michaelcik:0002127744
Issuer
ALTERITY THERAPEUTICS LTDcik:0001131343
Revision history · 0
No field has changed since this record was first ingested.
